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The adult human bronchial tree is covered with a continuous layer of
epithelial cells that play a critical role in maintaining the conduit for
air, and which are central to the defenses of the lung against inhaled
environmental concomitants. The epithelial sheet functions as an
interdependent unit with the other lung components. Importantly,
the structure and/or function of airway epithelium is deranged in
major lung disorders, including chronic obstructive pulmonary
disease, asthma, and bronchogenic carcinoma. Investigations re-
garding the airway epithelium have led to many advances over the
past few decades, but new developments in genetics and stem cell/
progenitor cell biology have opened the door to understanding how
the airway epithelium is developed and maintained, and how it
responds to environmental stress. This article provides an overview
of the current state of knowledge regarding airway epithelial stem/
progenitor cells, gene expression, cell–cell interactions, and less
frequent cell types, and discusses the challenges for future areas of
investigation regarding the airway epithelium in health and disease.
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The 221 to 223 branches of the adult human airways are covered
with a continuous epithelial sheet comprising less than 1% of
the total respiratory epithelial surface (1–3). The airway epithe-
lium is pseudostratified in the large airways, becoming columnar
and cuboidal in the small airways. The major cell types are
ciliated, columnar, undifferentiated, secretory and basal cells
(Figure 1). In the normal adult human, these epithelial cell popu-
lations vary as a function of airway level, with decreased num-
bers of cartilage cells and submucosal glands and the emergence
of Clara secretory cells as the airways branch from large to
small airways. There are a variety of less frequent cell types
throughout the airways, of which neuroendocrine cells have
attracted the most interest.
The airway epithelium plays a critical role in maintaining the
conduit for air to and from the alveoli (4). It is central to the
defenses of the lung against pathogens and particulates inhaled
from the environment, with the combined function of secretory
and ciliated cells maintaining efficient mucociliary clearance,
and a variety of other host defense processes (4–6). The epi-
thelial sheet does not function as an independent entity, but
rather as an interdependent functional unit with the other epi-
thelial cells, mesenchymal cells and endothelial cells, and the
extracellular matrix comprising the bronchial walls (4, 7). Im-
portantly, airway epithelial cells are central to the pathogenesis
of major lung disorders, including chronic obstructive pulmo-
nary disease (COPD), asthma, and bronchogenic carcinoma. In
these disorders, the function of the airway epithelium is further
modified by local inflammatory/immune signals (5, 6).
Although there have been significant advances over the past
few decades in understanding how the human airway epithelium
functions in health and disease, new developments in genetics
and stem cell/progenitor cell biology have significant implica-
tions for understanding how the airway epithelium develops,
how it is maintained, and how it responds to environmental
stress. In this context, the NHLBI workshop participants
focused on four topics relevant to the airway epithelium: (1)
airway epithelial stem/progenitor cells, (2) gene expression, (3)
cell–cell interactions, and (4) less frequent cell types.
AIRWAY EPITHELIAL STEM/PROGENITOR CELLS
The airway epithelium is a dynamic tissue normally undergoing
slow, but constant renewal. On the basis of studies in experi-
mental animals and limited studies in humans, the airway
epithelium likely turns over every 30 to 50 days (8). If injured,
unless the injury is too severe, extensive, or chronic, the airway
epithelium responds vigorously to reestablish an epithelial sheet
with normal structure and function, with resident cells as the
source of the new cell population (8–12). Although there may
be some contribution from circulating stem/progenitor cells,
most evidence supports the concept that stem/progenitor cells
distributed throughout the airway epithelium are the source of
the new epithelial cells, and that these stem/progenitor cells
have the potential to differentiate to all of the cell types of the
normal epithelium (13, 14). At present, there is no definitive
understanding of progenitor cell–progeny relationships in the
airway epithelium. It is not understood whether rare epithelial
stem/progenitor cells residing in specific niches proliferate,
migrate, and differentiate in a highly orchestrated process
similar to classical models of high turnover tissues, and/or if
alternative models of simple duplication of differentiated cells
are more applicable (14).
S. Randell (University of North Carolina) discussed basic
concepts relevant to airway epithelial stem/progenitor cells and
the murine models used to identify them. Notably, new lineage-
tracing studies question long-standing principles of stem cell
hierarchies even in well-understood rapid turnover tissues. The
notion of separate stem cell compartments for the follicular and
interfollicular epidermis has been challenged (15), and, in the
intestine, evidence suggests that a novel cell type at the tip of
the crypts, rather than the well-known cells at the 14 position,
are the stem cells (16). In the conditionally proliferative pan-
creas, cell replacement may occur via duplication of b-cells
rather than differentiation from a precursor cell type (17). Ad-
vances in the broader stem cell field require constant reevalua-
tion of even the well-known systems, and a major goal is to
apply developing concepts to the airways and lung. An up-to-
date review of lung stem cell biology is available (18).
The airway tree is complex and cell populations vary
systematically both by airway generation and by species (2).
Despite potential differences between animal models and
humans, current concepts in this field come mostly from studies
of the rodent airways and lung. Furthermore, the conditional
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nature of airway and lung cell proliferation typically requires
injury (bleomycin, naphthalene, SO2, transplantation, etc.) or
cell culture testing to experimentally recruit stem and pro-
genitor cells, which introduces uncertainty regarding broader
applicability to steady-state renewal and/or other types of re-
pair. Nevertheless, DNA metabolic pulse-labeling studies show
that both basal and columnar secretory cell populations of the
pseudostratified epithelium divide, albeit relatively infrequently
in normal airways (19, 20). Epithelial repair is rapidly induced
after injury (10), with both ‘‘dedifferentiation’’ and migration of
cells to cover defects, with proliferation and ‘‘redifferentiation’’
ongoing. Despite early data suggesting that only basal or
secretory cells were pluripotent, it appears that both basal and
columnar cells can reconstitute a full epithelium (21). Thus,
there is abundant plasticity within the tissue as indicated by
progenitor cells from multiple cell compartments. The rapid
migratory and proliferative response of the pseudostratified
airway epithelium likely indicates the high priority given to
repair of denuding epithelial injuries. Although secretory, non-
differentiated columnar and parabasal cells can proliferate (20),
the tentative consensus from DNA label-retention (22), lineage
mapping (23, 24), and in vitro studies (25) is that a subpopulation
of basal cells are most likely the stem cells of the pseudostra-
tified zone.
There are many unanswered questions regarding epithelial
stem and progenitor cells in the larger airways. In view of the
ongoing revision of basic stem cell hierarchies in general, have
the existing studies accurately identified niches in the pseudos-
tratified epithelium? What are the criteria for stem cells of this
tissue, and what assays are needed to find them? Do they express
unique molecular markers? What are the molecular relation-
ships between stem cells, the matrix, and lamina propria cells?
Will a better understanding of cell lineages and regulation
of proliferation and differentiation presage novel therapeutic
approaches to modulate airway epithelial phenotype? Are the
tissue stem cells targets for malignant transformation in bron-
chogenic carcinoma, and will understanding the stem cells as-
sist in the detection, monitoring, and treatment of this most
prevalent cancer?
Depending on species, basal cells disappear as one moves
from the trachea toward the alveoli. The epithelium becomes
simple columnar and then cuboidal in the small airways,
a critical zone for several common lung diseases, such as COPD
(26) and bronchiolitis obliterans, a severe complication of both
lung and allogenic hematopoietic stem cell transplantation that
limits long-term survival (27, 28). A tenable hypothesis is that
a relatively limited reservoir of stem cells renders small airways
susceptible to injury, phenotypic modulation, and, in some
cases, denudation followed by fibrotic obstruction. An insightful
murine model of small airway epithelial renewal is administra-
tion of naphthalene to mice, which causes death of the majority
of the Clara cell population due to selective metabolic activa-
tion of the toxin. Ciliated cells shed their cilia and migrate to
cover the denuded basement membrane (29–31), but do not ap-
pear to enter the cell cycle (32). A small proportion of variant
Clara cells residing within neuroepithelial bodies survive, and
are the source of cells that proliferate and differentiate to regen-
erate the epithelium (30), and this unit may function as a stem
cell niche. Another proposed airway epithelial stem/progenitor
cell niche is located near the junction of the bronchi and alveoli
(13, 33). A specific subset of epithelial cells reported to express
secretoglobin, family 1A, member 1 (SCGB1a1), surfactant
protein (SP)-C, CD-34, and stem cell antigen (Sca)-1 were found
to proliferate in response to injury, grow clonally in vitro, and
differentiate into Clara and alveolar epithelial cells, and were the
source of carcinoma in a model of Ras oncogene activation (13).
Further studies are clearly needed to better define the
spectrum of ‘‘stemness’’ within the small airway epithelial cell
population, to elucidate additional molecular markers for stem/
progenitor cells, to understand the molecular pathways regu-
lating their behavior, and to extend observations from murine
models to humans. A key question is whether therapies directed
at enhancing repair via modulation of stem and progenitor cell
regulatory pathways will be a reasonable approach to limit
injury and/or to preserve small airway function, and conversely
to inhibit growth and treat cancers that originate in this zone.
J. Engelhardt (University of Iowa) focused on the putative
niches for stem/progenitor cells in the lung. Several regions of
the airways likely provide specialized microenvironments that
regulate stem/progenitor cell behavior in the setting of airway
injury, repair, and maintenance. As in other organs, it is likely
that niche microenvironments in the lung can control intrinsic
stem/progenitor cell properties through cell–cell contact with
supporting cells, paracrine and endocrine signaling from either
local or distant sources, and/or neural input (34, 35). However,
unlike other organs such as the skin and gut for which stem cell
compartments are better characterized (36, 37), the unique
functional anatomy of the lung must support a number of
trophic units that span great distances. Each of these trophic
units contains a unique composition of cell types that serve
a unique function in the context of lung innate immunity and
gas exchange. Given the vast distances at the cellular level
between each of these trophic units—tracheobronchial, bron-
chiolar, and alveolar—it is currently believed that multiple adult
stem cell niches would be required to support each of these
unique cellular compartments (38).
Figure 1. Major cell types of the lung epithe-
lium. In the large airways (20 to 25 branches),
the major cells types are ciliated, undifferenti-
ated columnar, secretory, and basal cells. In the
small airways (26 to 223 branches), the cell types
are similar, with relatively more ciliated cells,
and the secretory cells shift to the Clara cell
type. After 223 branches, the airway epithelium
merges with the alveolar epithelium, with type I
and type II cells. Not shown are a variety of less
common cell types, such as cartilage cells and
mucus glands in the large airways, and neuro-
endocrine cells.
Crystal, Randell, Engelhardt, et al.: Airway Epithelial Cells 773
Submucosal glands have been suggested to serve as a stem
cell niche of the proximal cartilaginous airways, on the basis of
studies demonstrating that bromodeoxyuridine (5-bromo-2-
deoxyuridine) label–retaining cells, characterized by a slow-
cycling stem cell phenotype, reside in gland ducts of mouse
trachea after injury (22, 39). As discussed by S. Randell,
putative stem/progenitor cells in the bronchioles have been
associated with neuroepithelial bodies (30, 33). In this region,
a subpopulation of naphthalene-resistant Clara cells (termed
a variant Clara cell or Clarav) that express the Clara cell se-
cretory protein (CCSP) have been suggested to function as the
stem cells of the distal airways. In bronchioles, these cells ap-
pear to reside at airway branch points. Pulmonary neuroendo-
crine cells that reside within neuroendocrine bodies are be-
lieved to provide extrinsic components important for the stem
cell niche and maintenance of Clarav cells. Recently, an
additional potential niche has been identified at the bronchioal-
veolar duct junctions and contains a second type of Clarav that
expresses both CCSP and SP-C (an alveolar type II cell protein)
(13). In contrast to the bronchiolar airway, little is known about
the phenotype of glandular progenitor cells in the proximal
mouse airways. This region of the proximal airway differs be-
tween mouse and humans in that submucosal glands are limited to
the proximal trachea in mouse but are found throughout the
cartilaginous airways (i.e., tracheobronchial) in humans. There-
fore, the tracheobronchial progenitor/stem cell niche may be quan-
titatively and qualitatively different between mice and humans.
It has become increasingly recognized that dysfunction in the
microenvironment of a stem cell niche may contribute to the
emergence of disease (35). For example, in cystic fibrosis (CF),
significant airway glandular remodeling occurs in response to
lung infection, with alterations including glandular hypertrophy
(expansion of gland mass in existing glands) and metaplasia
(replacement of one cell phenotype with another; e.g., serous to
mucous cell) (40). Such changes suggest that glandular pro-
genitor/stem cells have altered biology as a result of lung injury
and infection. In support of this hypothesis, one study indicates
that submucosal gland hyperplasia (the formation of new
glands) may occur in the tracheas of CF mice (41), suggesting
that the number of proximal airway stem cell niches may be
increased in CF mice. Given the potential importance of sub-
mucosal glands as stem cell niches for the proximal airway,
studies evaluating functional components involved in the estab-
lishment of this niche will lead to a better appreciation of
changing airway niche characteristics in the setting of disease.
Relatively little is known about the signals and cell types
involved in airway progenitor/stem cell niche function and
whether they are conserved in nonrodent species.
Characterization of progenitor/stem cell niches in the lung
has been heavily dependent on the localization of a nucleotide
label-retention phenotype and a limited number of genetic
mouse strains with gene-specific promoters and gene products
to manipulate airway epithelial cell in vivo. Label-retention is
only one suggestive phenotype of an adult stem cell population
and caution must be used when drawing conclusions about
potential stem cell phenotypes without functional lineage
analysis (16). For example, after napthelene labeling in the
mouse, pulmonary endocrine cells expand and retain nucleotide
label. However, on the basis of genetic studies using thymidine
kinase ablation of CCSP-expressing Clara cells, pulmonary
endocrine cells are not capable of regenerating a ciliated airway
epithelium and therefore are not stem cells in the distal airways
of the mouse (30). We currently lack good markers for the
diversity of cell phenotypes in the lung, which are needed for
more definitive characterization of adult stem cell niches and
their phenotypes.
BIOLOGIC PHENOTYPING OF THE HUMAN
AIRWAY EPITHELIUM
R. Crystal (Weill Cornell Medical College) concentrated on
understanding the human airway epithelium at the genetic
level. The human airway epithelium is accessible to sampling
in humans using fiberoptic bronchoscopy and brushing. With
current technology, pure populations of large and small airway
epithelium can be repetitively sampled in normal individuals
and individuals with lung disease (12, 42–44), easily obtaining
5 3 106 epithelial cells. Using current sophisticated ’omics
technologies, the opportunity is ripe to characterize the pro-
gram of all 25,000 genes of the human airway epithelium at the
DNA, mRNA, protein, and metabolic levels in their baseline
state, under conditions of environmental stress and in disease
states.
Routine bronchoscopy with brushing permits repetitive
sampling of both large and small airway epithelium in
amounts adequate for application of microarray assessment
of expression of all human genes. Although air–liquid in-
terface cultures, the in vitro gold-standard culture represen-
tative of the human airway epithelium, are useful for a variety
of biologic studies, microarray comparison of mRNA expres-
sion patterns of air–liquid interface cultures of human large
airway epithelium to that of freshly isolated brushed sam-
ples of large airway epithelium of normal individuals shows
differences in the expression levels of hundreds of genes, with
the freshly isolated epithelium expressing more immune
response and mucin-related genes, and the cultures express-
ing more oxidant-related, growth factor, cell cycle, and
adhesion genes.
Strikingly, the small airway epithelium of cigarette smokers
who are phenotypically normal (no symptoms, normal lung
function, normal imaging) has approximately 300 genes signifi-
cantly up- or down-regulated compared with normal nonsmokers
(44). This is the biologic ‘‘smoking phenotype.’’ Interestingly,
there is considerable variability in the airway epithelium in
response to smoking, suggesting a genetic component in the
response to smoking (42, 45). Furthermore, normal smokers can
be ranked based on their average levels of gene expression in their
small airway epithelium as ‘‘high responders’’ and ‘‘low respond-
ers,’’ independent of age, sex, ancestry, or extent of smoking (i.e.,
humans vary in terms of the gene expression responses of the
airway epithelium to environmental stress) (46). There is also
evidence that ancestral background plays a role in the gene
expression responses of the airway epithelium, with those of
African descent having identifiable differences in their gene
expression patterns compared with those of European descent,
and specific single nucleotide polymorphisms dictating differ-
ences in airway epithelial gene expression (47). The frontier for
applying ’omics technologies to phenotyping the human airway
epithelium is to characterize each of the multiple cell types that
comprise the large and small airway epithelium, and to apply
’omics technologies to define the airway epithelial stem cell
populations, and the myriad of signals that control how the
airway epithelial population is maintained in health and disease.
Using ’omics technologies at the DNA, mRNA, protein, and
metabolic levels, it should be possible to develop different
phenotypes of the human large and small airway epithelium in
health, under environmental stress, and in disease states. A major
challenge in understanding the human airway epithelium is to
define how genomic variation modulates gene expression, and
therefore the phenotype of the cells comprising the epithelium,
and how this genomic variation defines risk for the major human
disorders of the airways, including COPD, asthma, and broncho-
genic carcinoma.
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CELL–CELL INTERACTIONS
J. Voynow (Duke University) focused her remarks on mucous
and ciliated cells and their interactions. Mucociliary clearance
has an important innate immune function in healthy airways,
with contributions by the ciliated cells in the conducting airway
epithelium and the secretory cells, including goblet cells and the
mucous and serous cells in the submucosal glands. Coordinated
ciliary motion clears mucus-bound particles from the airways.
Mucus binds infectious agents and particulates, but also has
antioxidant, antiprotease, and antimicrobial properties. These
functional properties are due to proteins (lysozyme, lactoferrin,
defensins, secretory leukocyte peptidase inhibitor [SPLI], lacto-
peroxidase) secreted by serous cells of the submucosal glands
(48), as well as CCSP from Clara cells, and SP-A and SP-D from
alveolar type II cells. However, the functional properties of the
major macromolecular constituent of mucus, the mucin glyco-
proteins, are far less well established.
The functional contributions of mucins are speculated to be
related to the hundreds of diverse O-glycosidic carbohydrate
structures, which are covalently bound to serine and threonine
residues in mucin protein backbones. These are predicted to be
important for lectin recognition by bacteria and leukocytes.
Another characteristic motif of secreted mucins, cysteine-rich
domains at the carboxyl- and amino-termini, are the sites for
oligomerization of mucins and are believed to confer biophys-
ical properties (aggregation, gel formation) of mucins and mucus.
However, there is little direct evidence that defines the func-
tional properties of specific carbohydrate structures or specific
motifs in mucin protein backbones. In addition to unique struc-
tural characteristics of mucins, expression of specific mucins
is restricted to different secretory cell types. For example,
MUC5AC is localized to goblet cells and MUC5B is localized
to mucous cells of submucosal glands in the healthy airway. The
impact of mucin segregation in different secretory cells on
secreted mucus function in healthy airways is not known (49).
The secretory cells are implicated in lung diseases as mucus
hypersecretion/overproduction, goblet cell hypertrophy and
hyperplasia, and submucosal gland hypertrophy, which are
common pathologic features of asthma, COPD, and CF. In
a mouse model of asthma, it has been demonstrated that
blocking mucus hypersecretion relieves airway obstruction
(50), providing an important rationale for investigating secre-
tory cell remodeling in chronic inflammatory airway diseases.
However, there is not a common paradigm underlying secretory
cell hyperplasia because these mechanisms likely vary for each
chronic inflammatory disease process (49), and also vary by the
severity of the insult. For example, airway epithelial cell pro-
liferation varies directly with disease severity in asthma (51), yet
goblet cell hyperplasia is present in patients with mild and
severe asthma (52). Mouse models of asthma do not demon-
strate increased airway epithelial proliferation and data support
the hypothesis of ‘‘transdifferentiation’’ from either ciliated (53)
or Clara cells (54) to goblet cells to explain secretory cell
remodeling. In contrast, after naphthalene-induced epithelial
injury and loss, lineage-tagged basal cells proliferate and
differentiate to repopulate ciliated, goblet, Clara, and basal cell
populations (24), and transdifferentiation of ciliated to goblet
cells does not occur (32).
Distinct signaling pathways also regulate goblet cell hyper-
plasia and differ according to the disease and the environmental
insult. In asthma, IL-13 and epidermal growth factor receptor
(EGFR) activate independent pathways to regulate goblet cell
hyperplasia (53). In COPD, tobacco smoke or reactive oxygen
species regulate goblet cell hyperplasia by either EGFR-de-
pendent or EGFR-independent pathways (55, 56). In mice,
overexpression of the epithelial sodium channel creates CF-like
primary defects of increased sodium absorption and diminished
airway surface liquid volume, resulting in goblet cell metaplasia
and mucus obstruction of airways (57). Finally, a profile of
secretory cell positive and negative regulatory transcription
factors is emerging with FoxA2 (58), a negative regulatory
factor for goblet cell metaplasia and catenin and SAM pointed
domain containing ETS transcription factor [SPDEF], positive
regulatory factors for goblet cell metaplasia (58). Although pro-
gress has been made in understanding mechanisms of secretory
cell metaplasia in the mouse, in humans there are many out-
standing questions concerning the fundamental properties of
airway mucins and mechanisms of secretory cell remodeling in
chronic inflammatory airway diseases.
Among the important questions to be answered regarding
the interactions of mucous and ciliated cells are the following:
1. What are the MUC species and their relative amounts in
normal mucus? How does this profile change in disease
states and what is the role of post-transcriptional and
epigenetic regulation?
2. What are the functions of secreted mucins? What is the
role of the carbohydrate diversity and the role of specific
motifs in mucin protein backbones?
3. How does mucus interact with cilia?
4. What is the machinery required for constitutive versus
stimulated exocytosis in secretory cells?
5. Are there local environmental or structural factors that
regulate normal development of goblet cells or submuco-
sal gland cells?
6. How are goblet cell hyperplasia and submucosal gland
remodeling regulated and what is the relative contribu-
tion of gland secretions to abnormal mucus?
7. What is the role of proliferation and differentiation versus
transdifferentiation in goblet cell hyperplasia and which
cells are the precursor cells?
8. Can secretory cell remodeling be reversed?
RARE CELL TYPES
Mary Sunday (Duke University) discussed pulmonary neuro-
endocrine cells (PNECs), a rare, but likely very important cell
of the airway epithelium. Although there are a number of other
important rare cell types, such as neural cells, PNECs appear to
play a number of roles that are unique in lung physiology in
health and disease. Their normal function and their role in lung
disease are only beginning to be understood. The cells have
dense-core neurosecretory granules containing serotonin and
numerous bioactive peptides, including calcitonin and gastrin-
releasing peptide (GRP). The relative numbers of PNECs and
tissue levels of GRP and GRP mRNA are highest at midges-
tation in human fetal lung, which corresponds to the canalicular
phase of development. Recent studies have shown that GRP
promotes proliferation and differentiation of type II cells and
PNECs in lung explants from mice, humans, and baboons and
mice in vivo. Focusing on the PNEC hyperplasia associated with
bronchopulmonary dysplasia (BPD), studies in premature ba-
boon models showed that increased GRP production and
elevated numbers of PNECs occur within days of birth, and
correlate with elevated urine GRP levels. In contrast, clinical
and pathologic evidence of BPD takes weeks to develop. In
premature infants who went on to develop BPD months later,
mean urine GRP levels doubled in the first 5 days of life. To
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address the mechanisms underlying this association, premature
baboons were treated with a blocking anti-GRP antibody,
which resulted in abrogation of both clinical and pathologic
parameters of BPD. These studies help define GRP as a medi-
ator of lung injury in BPD and suggest that PNECs function as
part of the innate immune system.
RECOMMENDATIONS RELEVANT TO THE
AIRWAY EPITHELIUM
1. Using gene expression at the mRNA, protein, metabolic,
and immunohistochemical levels, identify markers for
each of the categories of airway epithelial differentiated
cells. It is likely that there are subpopulations of airway
epithelial cells with similar morphology, but with distinct
differences in gene expression. Generate monoclonal
antibodies specific for each cell type that can be used to
detect and isolate specific airway epithelial cell types in
mice and humans.
2. Develop a consensus as to the definitions of lung stem/
progenitor cells and the assay criteria needed to define
these populations. Isolate, characterize, and develop
markers specific for airway epithelial stem/progenitor
cells. Study the biology of airway epithelial cell ‘‘stem-
ness,’’ and define the complex signaling pathways that
direct airway epithelial stem/progenitor cells to differen-
tiate to distinct epithelial cell types.
3. Develop methods to isolate specific cell populations of the
human airway epithelium, and use ’omics technologies to
characterize the individual cell types in health, under
environmental stress and in disease states.
4. Using morphologic and gene expression strategies, char-
acterize the changes in the cell composition of the de-
veloping perinatal and childhood airway epithelium lung.
Analogous to the efforts of the NHLBI-funded Lung
Tissue Research Consortium for COPD and IPF, a funda-
mental step forward would be to identify and/or create
a tissue bank of well-characterized human airway samples
encompassing this critical developmental period.
5. Develop murine models to enable precise lineage mapping
of airway epithelial stem/progenitor cells, and the differ-
entiation of these cells in the normal lung and after injury.
6. Invest in new methodologies to lineage-tag specific hu-
man airway epithelial cells. This advance would provide
a tool to definitively study specific cellular function and
cellular adaptation under conditions of stress or disease in
the context of the whole organ. It could be used to
evaluate the impact of epigenetic regulation of genotypes
in health and disease and to evaluate cell interactions
between different tissues in the lung.
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